Historical salary details - Mr. Steven D. Rubin, Independent Director, Cocrystal Pharma Inc
Mr. Steven D. Rubin is the Independent Director of Cocrystal Pharma Inc. They also hold 3 other positions in Niagen Bioscience Inc., Opko Health Inc and Red Violet Inc.
Mr. Steven D. Rubin
Independent Director
-
Gross Remuneration
-
Current Company
Cocrystal Pharma Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Cocrystal Pharma Inc | Independent Director | - | - |
| 2024 | Niagen Bioscience Inc. | Lead Independent Director | - | - |
| 2024 | Opko Health Inc | Director and Executive Vice President, Administrat | - | - |
| 2024 | Red Violet Inc | Independent Director | - | - |
| 2023 | Red Violet Inc | Independent Director | 250.9 K | 20.9 % |
| 2023 | Niagen Bioscience Inc. | Lead Independent Director | 117.3 K | 20.2 % |
| 2023 | Cocrystal Pharma Inc | Independent Director | 113.5 K | -13.2 % |
| 2023 | Opko Health Inc | Director and Executive Vice President, Administrat | - | - |
| 2022 | Red Violet Inc | Independent Director | 207.6 K | -24.8 % |
| 2022 | Cocrystal Pharma Inc | Independent Director | 130.8 K | 10.4 % |
| 2022 | Niagen Bioscience Inc. | Independent Director | 97.6 K | -45.2 % |
| 2022 | Eloxx Pharmaceuticals Inc | Independent Director | 58.6 K | -26.0 % |
| 2022 | Opko Health Inc | Director and Executive Vice President, Administrat | - | - |
| 2021 | Red Violet Inc | Independent Director | 276.1 K | 51.7 % |
| 2021 | Niagen Bioscience Inc. | Independent Director | 178.1 K | 71.6 % |
| 2021 | Cocrystal Pharma Inc | Independent Director | 118.5 K | 53.9 % |
| 2021 | Eloxx Pharmaceuticals Inc | Independent Director | 79.2 K | -22.4 % |
| 2021 | Opko Health Inc | Director and Executive Vice President, Administrat | - | - |
| 2020 | Red Violet Inc | Independent Director | 182.0 K | -11.3 % |
| 2020 | Niagen Bioscience Inc. | Independent Director | 103.8 K | 9.6 % |
| 2020 | Eloxx Pharmaceuticals Inc | Independent Director | 102.1 K | -42.3 % |
| 2020 | Cocrystal Pharma Inc | Independent Director | 77 K | - |
| 2020 | Opko Health Inc | Director and Executive Vice President, Administrat | - | - |
| 2019 | Red Violet Inc | Independent Director | 205.3 K | -34.7 % |
| 2019 | Eloxx Pharmaceuticals Inc | Independent Director | 177.1 K | -82.1 % |
| 2019 | Niagen Bioscience Inc. | Independent Director | 94.7 K | 5.0 % |
| 2019 | Opko Health Inc | Director and Executive Vice President, Administrat | - | - |
| 2019 | BioCardia Inc. | Independent Director | - | - |
| 2019 | Cocrystal Pharma Inc | Independent Director | - | - |
| 2018 | Eloxx Pharmaceuticals Inc | Independent Director | 988.3 K | 3507.1 % |
| 2018 | VBI Vaccines Inc. | - | 347.6 K | 297.8 % |
| 2018 | Red Violet Inc | Independent Director | 314.3 K | - |
| 2018 | Cocrystal Pharma Inc | Independent Director | 105.4 K | - |
| 2018 | Niagen Bioscience Inc. | Independent Director | 90.2 K | -34.4 % |
| 2018 | Opko Health Inc | Director and Executive Vice President, Administrat | - | - |
| 2018 | VBI Vaccines Inc. | Independent Director | - | - |
| 2018 | Fluent Inc | Independent Director | - | - |
| 2017 | Eloxx Pharmaceuticals Inc | Independent Director | 236.3 K | - |
| 2017 | Fluent Inc | Independent Director | 140 K | -23.1 % |
| 2017 | Niagen Bioscience Inc. | Independent Director | 137.6 K | - |
| 2017 | VBI Vaccines Inc. | Independent Director | 87.4 K | -71.8 % |
| 2017 | Eloxx Pharmaceuticals Inc | - | 27.4 K | - |
| 2017 | Cocrystal Pharma Inc | Independent Director | - | - |
| 2017 | Opko Health Inc | Director and Executive Vice President, Administrat | - | - |
| 2017 | Red Violet Inc | Independent Director | - | - |
| 2016 | VBI Vaccines Inc. | Independent Director | 310.3 K | - |
| 2016 | Fluent Inc | Independent Director | 182 K | -91.5 % |
| 2016 | Eloxx Pharmaceuticals Inc | Independent Director | - | - |
| 2016 | Opko Health Inc | Director and Executive Vice President, Administrat | - | - |
| 2016 | Cocrystal Pharma Inc | Independent Director | - | - |
| 2016 | Niagen Bioscience Inc. | Independent Director | - | - |
| 2015 | Fluent Inc | Independent Director | 2.1 M | 8475.0 % |
| 2015 | Cocrystal Pharma Inc | Independent Director | 378.8 K | - |
| 2015 | Eloxx Pharmaceuticals Inc | Independent Director | - | - |
| 2015 | Opko Health Inc | Director and Executive Vice President, Administrat | - | - |
| 2014 | Fluent Inc | Independent Director | 25 K | - |
| 2014 | Eloxx Pharmaceuticals Inc | Independent Director | - | - |
| 2014 | Opko Health Inc | Director and Executive Vice President, Administrat | - | - |
| 2014 | Cocrystal Pharma Inc | Independent Director | - | - |
| 2013 | Fluent Inc | Independent Director | - | - |
| 2013 | BioCardia Inc. | Independent Director | - | - |
| 2013 | Opko Health Inc | Director and Executive Vice President-Administrati | - | - |
| 2013 | Cocrystal Pharma Inc | Independent Director | - | - |
| 2012 | BioCardia Inc. | Independent Director | - | - |
| 2012 | Fluent Inc | Independent Director | - | - |
| 2012 | Opko Health Inc | Director and Executive Vice President-Administrati | - | - |
| 2011 | Opko Health Inc | Director and Executive Vice President-Administrati | - | - |
| 2011 | BioCardia Inc. | Independent Director | - | - |
| 2011 | Fluent Inc | Independent Director | - | - |
| 2010 | Opko Health Inc | Director and Executive Vice President-Administrati | - | - |
| 2010 | Fluent Inc | Independent Director | - | - |
| 2010 | BioCardia Inc. | Director | - | - |
| 2009 | Fluent Inc | Director | 3.3 K | - |
| 2009 | BioCardia Inc. | Director | - | - |
| 2009 | Opko Health Inc | Director and Executive Vice President-Administrati | - | - |
| 2008 | BioCardia Inc. | Director | 5 K | - |
| 2008 | Opko Health Inc | Executive Vice President, Administration and Direc | - | - |
| 2007 | Opko Health Inc | Executive Vice President, Administration and Direc | - | - |
| 2006 | Opko Health Inc | Director and Executive Vice President, Administrat | - | - |
| 2006 | Fluent Inc | Secretary and Director | - | - |